Press Releases

NDD Medical Technologies reinforces commitment to respiratory therapy professionals with new spirometry training webinars

NDD Medical Technologies, the leading provider of pulmonary function equipment, is now offering free, live spirometry training sessions to provide respiratory professionals with renewed confidence in lung function testing for the most accurate results. NDD’s accurate and portable EasyOne® product line is dedicated to the early detection and accurate diagnosis of COPD and other chronic lung diseases. The new training webinars reinforce the company’s continued commitment to supporting medical professionals—particularly in the wake of the COVID-19 pandemic.

Shimmer to Highlight Its Verisense Wearable Sensing Platform for Clinical Trials and OWEAR, the Open Wearables Initiative, at the DPHARM Virtual Conference

The Verisense platform was built from the ground up to monitor clinical trial participants’ activity and sleep levels remotely. It was developed to satisfy the needs of, and place minimum burden on, all the stakeholders – sponsors, clinical research organizations (CROs), trial sites, and participants. OWEAR is an industry collaboration, which is developing a database of open source software and datasets, together with validation papers, for wearable sensors and other connected health technologies at www.owear.org.

AusDiagnostics opens state-of-the-art production facility and launches new extraction kit product line to target SARS-CoV-2 and infections beyond the pandemic

AusDiagnostics has opened a new state-of-the-art production facility in Sydney, alongside the launch of their new Puryx extraction kit product line.

Promega Launches Spectrum Compact CE Benchtop DNA Analysis Instrument with Hitachi High-Tech

New Zealand’s Ubiquitome signs NIH RADx contract

Ubiquitome, the only company outside the US, has received NIH RADx funds to develop its open RT-PCR the Liberty16 to test for COVID-19 in US hospitals and mobile labs

Iceni Diagnostics appoints BBI to produce its Covid-19/Influenza test

New Scanogen Study in Nature Communications Outlines Breakthrough Molecular Detection Technology

Scanogen, a pioneer molecular diagnostic company delivering revolutionary diagnostic solutions for sepsis and other infectious diseases, announced the findings from a new study published in Nature Communications that demonstrate the ability of a new technology to detect pathogens in whole blood with superior performance than amplification-based molecular technologies. The novel approach is at the basis of the system that the Company is developing to dramatically reduce the time it takes to identify sepsis associated pathogens from days to one hour.

SB3000 the life science technology company establishes its HQ in Copenhagen

Swedish Biomimetics 3000 Ltd, a life science technology company which has developed a world leading green technology platform used in the continuous manufacturing of pharmaceuticals, has established a new head office and scientific research facilities in Copenhagen. The company, which is called Swedish Biomimetics 3000 ApS, believes that it will benefit from the sector specific expertise in Denmark in expanding its capabilities. Going forward, the company will have key operations in both the UK and Denmark.

BOC Sciences Launches A New Liposome Technology Platform

Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking

New Alfa Laval Fluid Handling Application & Innovation Centre opens in Denmark

Panthera Biopartners concludes Series A financing with Gresham House Ventures as major investor

Panthera Biopartners (Panthera) has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.

VERICHEM LABORATORIES OFFERS LIQUID STABLE, READY-TO-USE, MULTI-ANALYTE ELECTROLYTE STANDARD KIT

VERICHEM LABORATORIES has announced the availability of a ready-to-use, liquid stable Electrolyte Standard Kit intended for the calibration and calibration verification of a number of diagnostic assays measured on a wide variety of clinical testing systems.

BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System

Alfa Chemistry Materials Offers Wide Options of Resins for Decoration or Manufacture of Plastics

AI & Medicine’s Drug Research and Development Platform Assists Biomarker Discovery

Study Shows Proof of Concept of BioIVT HEPATOPAC Cultures with Targeted Assay to Evaluate Bioactivation Potential and Drug-induced Liver Injury (DILI) Risk

New in vitro Bioactivation Liver Response Assay used HEPATOPAC model to demonstrate utility of in vitro transcriptomic signature-based strategy in preclinical DILI risk assessment

WCG Leads the Way and Sets a New Standard - Announcing the Formation of WCG IRB and the Launch of New WCG IRB Connexus™

WCG has unified its five IRBs – Western IRB (WIRB), Copernicus Group IRB, Midlands IRB, New England IRB, and Aspire IRB – in a single brand, WCG IRB. It has also launched a new technology – WCG IRB Connexus – to support clients’ ethical review submissions and management. Further information is available on it new website at www.wcgirb.com.

First Databank Selected as Drug Database Provider for CliniComp, Intl.’s Full-Service EHR Pharmacy Solution

For busy hospital clinicians making key medication decisions, minutes matter. They need up-to-the-minute reliable, authoritative drug information integrated into the EHR for better clinical decision-making at the point of care and to support alerts, interoperability and smarter data analytics. With drug information changing daily, that information also needs to be updated as soon as evidence-based knowledge and FDA guidance change--and it needs to be available immediately via the cloud rather than requiring frequent downloads. For all of those reasons, CliniComp Intl. has inked a deal with First Databank (FDB), the industry’s most trusted drug database, to drive streamlined inpatient pharmacy workflows for hospitals using the CliniComp’s EHR.

BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research

Applications for this model include assessing drug candidates’ hepatotoxicity, and studying inflammation-related diseases